Literature DB >> 20370498

Acetyl-L-carnitine supplementation to old rats partially reverts the age-related mitochondrial decay of soleus muscle by activating peroxisome proliferator-activated receptor gamma coactivator-1alpha-dependent mitochondrial biogenesis.

Vito Pesce1, Flavio Fracasso, Pierluigi Cassano, Angela Maria Serena Lezza, Palmiro Cantatore, Maria Nicola Gadaleta.   

Abstract

The age-related decay of mitochondrial function is a major contributor to the aging process. We tested the effects of 2-month-daily acetyl-L-carnitine (ALCAR) supplementation on mitochondrial biogenesis in the soleus muscle of aged rats. This muscle is heavily dependent on oxidative metabolism. Mitochondrial (mt) DNA content, citrate synthase activity, transcript levels of some nuclear- and mitochondrial-coded genes (cytochrome c oxidase subunit IV [COX-IV], 16S rRNA, COX-I) and of some factors involved in the mitochondrial biogenesis signaling pathway (peroxisome proliferator-activated receptor gamma [PPARgamma] coactivator-1alpha [PGC-1alpha], mitochondrial transcription factor A mitochondrial [TFAM], mitochondrial transcription factor 2B [TFB2]), as well as the protein content of PGC-1alpha were determined. The results suggest that the ALCAR treatment in old rats activates PGC-1alpha-dependent mitochondrial biogenesis, thus partially reverting the age-related mitochondrial decay.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370498     DOI: 10.1089/rej.2009.0955

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  9 in total

Review 1.  Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

Authors:  Gregory E Bigford; Gianluca Del Rossi
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

2.  Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the L-carnitine content in the rat heart.

Authors:  Luis A Gómez; Shi-Hua D Heath; Tory M Hagen
Journal:  Mech Ageing Dev       Date:  2012-02-01       Impact factor: 5.432

Review 3.  Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs.

Authors:  Vincenzo Tragni; Guido Primiano; Albina Tummolo; Lucas Cafferati Beltrame; Gianluigi La Piana; Maria Noemi Sgobba; Maria Maddalena Cavalluzzi; Giulia Paterno; Ruggiero Gorgoglione; Mariateresa Volpicella; Lorenzo Guerra; Domenico Marzulli; Serenella Servidei; Anna De Grassi; Giuseppe Petrosillo; Giovanni Lentini; Ciro Leonardo Pierri
Journal:  Molecules       Date:  2022-05-29       Impact factor: 4.927

4.  Sex dependent alterations in mitochondrial electron transport chain proteins following neonatal rat cerebral hypoxic-ischemia.

Authors:  T G Demarest; R A Schuh; E L Waite; J Waddell; M C McKenna; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2016-09-28       Impact factor: 2.945

5.  Molecular mechanisms for age-associated mitochondrial deficiency in skeletal muscle.

Authors:  Akira Wagatsuma; Kunihiro Sakuma
Journal:  J Aging Res       Date:  2012-04-04

Review 6.  Treatment strategies for inherited optic neuropathies: past, present and future.

Authors:  P Yu-Wai-Man; M Votruba; A T Moore; P F Chinnery
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

Review 7.  Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity.

Authors:  James J DiNicolantonio; Mark F McCarty; Simon Iloki Assanga; Lidianys Lewis Lujan; James H O'Keefe
Journal:  Open Heart       Date:  2022-03

8.  Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer's disease in vitro model.

Authors:  Sandra I Mota; Inês Pita; Rodolfo Águas; Slah Tagorti; Ashraf Virmani; Frederico C Pereira; A Cristina Rego
Journal:  Arch Toxicol       Date:  2021-06-24       Impact factor: 5.153

9.  Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.

Authors:  Giuseppe Sirago; Elena Conte; Flavio Fracasso; Antonella Cormio; Jean-Alain Fehrentz; Jean Martinez; Clara Musicco; Giulia Maria Camerino; Adriano Fonzino; Laura Rizzi; Antonio Torsello; Angela Maria Serena Lezza; Antonella Liantonio; Palmiro Cantatore; Vito Pesce
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.